
20th Annual Congress
COLLABORATION
GLOBAL LEARNING OBJECTIVES
By the end of this event, participants will be able to:
-
Evaluate evidence-based treatment options for brain metastases in patients with gynecologic cancer and select appropriate strategies for individual cases.
-
Explain the implementation of HPV testing and self-screening protocols for cervical cancer prevention in clinical practice, in alignment with updated guidelines.
-
Apply principles of just culture and burnout prevention strategies to enhance resilience and improve workplace well-being.
-
Integrate sentinel lymph node biopsy into the management of endometrial cancer and interpret the implications of isolated tumor cells for adjuvant treatment decisions.
-
Manage endometrial intraepithelial neoplasia using current diagnostic criteria and treatment options based on recent research.
-
Describe the mechanisms, indications, and side effects of antibody-drug conjugates in gynecologic oncology and assess their clinical utility.
-
Evaluate the role of radiotherapy in the treatment of gynecologic sarcomas and justify its use based on tumor characteristics.
-
Address sexual health challenges in gynecologic cancer survivors and recommend evidence-based interventions to improve intimacy.
-
Summarize key findings from 2024–2025 publications on ovarian, endometrial, and cervical neoplasms and discuss their implications for clinical practice.
These learning objectives align with the CanMEDS framework and promote the development of competencies such as medical expertise, communication, collaboration, and professionalism.

The congress program is subject to minor modifications at the discretion of the scientific committee.
SATURDAY, NOVEMBER 22, 2025
7:50-8:00AM
Official opening of the congress
Dr. Laurence Bernard and Dr. Léonie Dallaire-Nantel
8:00-8:45AM
New developments in Antibody-drug conjugates (ADCs)
Dr. Robert Coleman
Texas Oncology
8:45-9:00AM
Questions and Answers
9:00-9:30AM
Treatment of brain metastases
Dr. David Fortin
Neurosurgeon, Université de Sherbrooke
9:30-9:40AM
Questions and Answers
9:40-10:10AM
Cervical Cancer Prevention: Transition to HPV Testing and the Place of Self-Screening
Dr. Jessica Ruel Laliberté
10:10-10:20AM
Questions and Answers
10:20-10:50AM
Break and networking with exhibitors
10:50-11:10AM
Ovarian neoplasia highlights
Dr. Hisham Makki
Université Laval
11:10-11:20AM
Questions and Answers
10:50-11:10AM
Cervical neoplasia highlights
Fellow
Université de Montréal
11:10-11:20AM
Questions and Answers
11:20-11:40AM
Endometrial neoplasia highlights
Fellow
McGill University
11:40-11:50AM
Questions and Answers
12:20-12:30PM
To be confirmed
Ovarian Cancer Canada
12:30 p.m.
Adjournment for the day
6:00PM
Cocktail
Le Parlementaire
19H00
Dinner
Le Parlementaire
SUNDAY, NOVEMBER 23, 2025
8:00-8:45AM
Endometrial cancer: Sentinel lymph nodes and adjuvant therapy of isolated tumor cells (ITC)
To be confirmed
8:45-9:00AM
Questions and Answers
9:00-9:30AM
To be confirmed
Dr. Robert Coleman
Texas Oncology
9:30-9:40AM
Questions and Answers
9:40-10:10AM
Sexuality and intimacy after gynecological cancer
Mrs. Gabriella Michetti
Nurse practitioner, MUHC
10:10-10:20AM
Questions and Answers
10:20-10:50
Break and networking with exhibitors
10:50-11:20AM
Just Culture in Medicine and Burnout Prevention
Dr. Marianne Archambeault
11:20-11:30AM
Questions and Answers
11:30AM - 12:00PM
-
Management of endometrioid intraepithelial neoplasia (EIN)
-
Update on the RGOQ research project on EINs
Dr. Marie-Hélène Auclair and Dr. Omar Touhami
12:00-12:10PM
Questions and Answers
12:10PM
Adjournment for the day
Venues
Join us for the 20th Annual Congress, which will take place in the Multi-Purpose Hall of the CHU de Québec – Université Laval, located at 2260 Boul. Henri-Bourassa, Québec (Québec) G1J 5B3.
To conclude the congress, we invite you to a celebratory dinner at Le Parlementaire restaurant, a unique venue that showcases the flavors of Québec. Featuring a menu crafted with local ingredients from various regions, this elegant establishment offers a refined dining experience in the historic setting of the National Assembly of Québec.
We look forward to celebrating this special occasion with you!

Scientific Committee
Become Our Partner
RGOQ is the partner of choice for healthcare organizations, hospitals, patient advocacy groups, pharmaceutical companies, and medical device manufacturers that share our vision and commitment. By partnering with us, you join a network of professionals and organizations dedicated to improving patient outcomes and advancing the field of gynecologic oncology.